News – Seaport Therapeutics

Press Release - 2024-12-11

Seaport

Seaport Therapeutics Presents Additional Data from Phase 1 Study of SPT-300 at ACNP Annual Meeting 2024

Press Release - 2024-11-20

Seaport Therapeutics Adds Sandi Peterson to its Board of Directors

Press Release - 2024-11-05

Seaport

Seaport Therapeutics Names Lauren White as Chief Financial Officer

Press Release - 2024-10-21

Seaport

Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing Round

Press Release - 2024-08-13

Seaport

Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors

Press Release - 2024-06-18

Seaport

Seaport Therapeutics Appoints Seasoned Executives to Management Team

Press Release - 2024-05-09

Seaport

Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting

Press Release - 2024-05-07

Seaport

Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments

Press Release - 2024-04-09

Seaport

Seaport Therapeutics Launches with $100 Million Oversubscribed Series A Financing Round to Advance Novel Neuropsychiatric Medicines